Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1

Status

Completed 28Terminated 10Unknown 4Withdrawn 1Suspended 1

Sponsor Class

INDUSTRY 2OTHER_GOV 1OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 2Hyperplasia 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Calcitriol × Clear all
NCT00926315 2012-11-01

Gene Expression Profile of Breast Cancer Samples After Vitamin D Supplementation

University of Sao Paulo General Hospital

Phase NA Unknown
60 enrolled
Breast

Breast Neoplasms, Hyperplasia

NCT01039181 2009-12-24

Calcitriol in Advanced Intrahepatic Cholangiocarcinoma

National Science and Technology Development Agency, Thailand

Phase 2 Unknown
28 enrolled
Gastrointestinal

Cholangiocarcinoma

NCT00043576 2009-03-12

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Novacea

Phase 2/3 Unknown
250 enrolled
Genitourinary

Prostatic Neoplasms

NCT00285675 2006-05-31

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Novacea

Phase 2 Unknown
25 enrolled
GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡